Cargando…

CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway

Cullin4B (CUL4B) is a scaffold protein of the CUL4B‐Ring E3 ligase (CRL4B) complex. However, the role of CUL4B in the development of breast cancer remains poorly understood. Here it is shown that CRL4B interacts with multiple histone deacetylase (HDAC)‐containing corepressor complexes, including MTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei, Zhang, Jingyao, Huo, Miaomiao, Gao, Jie, Yang, Tianshu, Yin, Xin, Wang, Pei, Leng, Shuai, Feng, Dandan, Chen, Yang, Yang, Yang, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132058/
https://www.ncbi.nlm.nih.gov/pubmed/34026424
http://dx.doi.org/10.1002/advs.202001515
_version_ 1783694842597998592
author Huang, Wei
Zhang, Jingyao
Huo, Miaomiao
Gao, Jie
Yang, Tianshu
Yin, Xin
Wang, Pei
Leng, Shuai
Feng, Dandan
Chen, Yang
Yang, Yang
Wang, Yan
author_facet Huang, Wei
Zhang, Jingyao
Huo, Miaomiao
Gao, Jie
Yang, Tianshu
Yin, Xin
Wang, Pei
Leng, Shuai
Feng, Dandan
Chen, Yang
Yang, Yang
Wang, Yan
author_sort Huang, Wei
collection PubMed
description Cullin4B (CUL4B) is a scaffold protein of the CUL4B‐Ring E3 ligase (CRL4B) complex. However, the role of CUL4B in the development of breast cancer remains poorly understood. Here it is shown that CRL4B interacts with multiple histone deacetylase (HDAC)‐containing corepressor complexes, including MTA1/NuRD, SIN3A, CoREST, and NcoR/SMRT complexes. It is demonstrated that CRL4B/NuRD(MTA1) complexes cooccupy the E‐cadherin and AXIN2 promoters, and could be recruited by transcription factors including Snail and ZEB2 to promote cell invasion and tumorigenesis both in vitro and in vivo. Remarkably, CUL4B responded to transformation and migration/invasion stimuli and is essential for multiple epithelial‐mesenchymal transition (EMT) signaling pathways such as hypoxia. Furthermore, the transcription of CUL4B is directedly activated by hypoxia‐inducible factor 1α (HIF1α) and repressed by the ERα‐GATA3 axis. Overexpressing of CUL4B successfully induced CSC‐like properties. Strikingly, CUL4B expression is markedly upregulated during breast cancer progression and correlated with poor prognosis. The results suggest that CUL4B lies at a critical crossroads between EMT and stem cell properties, supporting CUL4B as a potential novel target for the development of anti‐breast cancer therapy.
format Online
Article
Text
id pubmed-8132058
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81320582021-05-21 CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway Huang, Wei Zhang, Jingyao Huo, Miaomiao Gao, Jie Yang, Tianshu Yin, Xin Wang, Pei Leng, Shuai Feng, Dandan Chen, Yang Yang, Yang Wang, Yan Adv Sci (Weinh) Full Papers Cullin4B (CUL4B) is a scaffold protein of the CUL4B‐Ring E3 ligase (CRL4B) complex. However, the role of CUL4B in the development of breast cancer remains poorly understood. Here it is shown that CRL4B interacts with multiple histone deacetylase (HDAC)‐containing corepressor complexes, including MTA1/NuRD, SIN3A, CoREST, and NcoR/SMRT complexes. It is demonstrated that CRL4B/NuRD(MTA1) complexes cooccupy the E‐cadherin and AXIN2 promoters, and could be recruited by transcription factors including Snail and ZEB2 to promote cell invasion and tumorigenesis both in vitro and in vivo. Remarkably, CUL4B responded to transformation and migration/invasion stimuli and is essential for multiple epithelial‐mesenchymal transition (EMT) signaling pathways such as hypoxia. Furthermore, the transcription of CUL4B is directedly activated by hypoxia‐inducible factor 1α (HIF1α) and repressed by the ERα‐GATA3 axis. Overexpressing of CUL4B successfully induced CSC‐like properties. Strikingly, CUL4B expression is markedly upregulated during breast cancer progression and correlated with poor prognosis. The results suggest that CUL4B lies at a critical crossroads between EMT and stem cell properties, supporting CUL4B as a potential novel target for the development of anti‐breast cancer therapy. John Wiley and Sons Inc. 2021-03-16 /pmc/articles/PMC8132058/ /pubmed/34026424 http://dx.doi.org/10.1002/advs.202001515 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Papers
Huang, Wei
Zhang, Jingyao
Huo, Miaomiao
Gao, Jie
Yang, Tianshu
Yin, Xin
Wang, Pei
Leng, Shuai
Feng, Dandan
Chen, Yang
Yang, Yang
Wang, Yan
CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
title CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
title_full CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
title_fullStr CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
title_full_unstemmed CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
title_short CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
title_sort cul4b promotes breast carcinogenesis by coordinating with transcriptional repressor complexes in response to hypoxia signaling pathway
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132058/
https://www.ncbi.nlm.nih.gov/pubmed/34026424
http://dx.doi.org/10.1002/advs.202001515
work_keys_str_mv AT huangwei cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT zhangjingyao cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT huomiaomiao cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT gaojie cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT yangtianshu cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT yinxin cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT wangpei cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT lengshuai cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT fengdandan cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT chenyang cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT yangyang cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway
AT wangyan cul4bpromotesbreastcarcinogenesisbycoordinatingwithtranscriptionalrepressorcomplexesinresponsetohypoxiasignalingpathway